{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:39:07Z","timestamp":1789799947366,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13018-017-0660-6","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T05:43:50Z","timestamp":1509083030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The efficacy of tranexamic acid using oral administration in total knee arthroplasty: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Lu-kai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-jie","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"issue":"7476","key":"660_CR1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/bmj.329.7476.1220","volume":"329","author":"S Gidwani","year":"2004","unstructured":"Gidwani S, Fairbank A. The orthopaedic approach to managing osteoarthritis of the knee. BMJ. 2004;329(7476):1220\u20134.","journal-title":"BMJ"},{"issue":"13","key":"660_CR2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/JBJS.K.00873","volume":"94","author":"ZG Yang","year":"2012","unstructured":"Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012;94(13):1153\u20139.","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"660_CR3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1302\/0301-620X.96B8.33745","volume":"96-b","author":"S Alshryda","year":"2014","unstructured":"Alshryda S, et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J. 2014;96-b(8):1005\u201315.","journal-title":"Bone Joint J"},{"key":"660_CR4","doi-asserted-by":"crossref","first-page":"g4829","DOI":"10.1136\/bmj.g4829","volume":"349","author":"J Poeran","year":"2014","unstructured":"Poeran J, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.","journal-title":"BMJ"},{"issue":"1","key":"660_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13018-017-0512-4","volume":"12","author":"TP Chen","year":"2017","unstructured":"Chen TP, et al. Comparison of the effectiveness and safety of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):11.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"660_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13018-017-0520-4","volume":"12","author":"JF Li","year":"2017","unstructured":"Li JF, et al. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. J Orthop Surg Res. 2017;12(1):22.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"660_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13018-017-0559-2","volume":"12","author":"B Mi","year":"2017","unstructured":"Mi B, et al. Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):61.","journal-title":"J Orthop Surg Res"},{"issue":"12","key":"660_CR8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1302\/0301-620X.93B12.26989","volume":"93","author":"S Alshryda","year":"2011","unstructured":"Alshryda S, et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011;93(12):1577\u201385.","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"660_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.knee.2013.05.014","volume":"20","author":"M Panteli","year":"2013","unstructured":"Panteli M, et al. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee. 2013;20(5):300\u20139.","journal-title":"Knee"},{"issue":"6","key":"660_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.annfar.2004.04.012","volume":"23","author":"MM Lucaspolomeni","year":"2004","unstructured":"Lucaspolomeni MM, et al. A case of anaphylactic shock with tranexamique acid (Exacyl). Ann Fr Anesth Reanim. 2004;23(6):607\u20139.","journal-title":"Ann Fr Anesth Reanim"},{"issue":"5","key":"660_CR11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365540903510690","volume":"42","author":"M Klak","year":"2010","unstructured":"Klak M, et al. Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis. 2010;42(5):351\u20138.","journal-title":"Scand J Infect Dis"},{"key":"660_CR12","doi-asserted-by":"crossref","unstructured":"Zhang LK, et al. Comparison of oral versus intravenous application of tranexamic acid in total knee and hip arthroplasty: A systematic review and meta-analysis. Int J Surg. 2017;45:77\u201384.","DOI":"10.1016\/j.ijsu.2017.07.097"},{"key":"660_CR13","doi-asserted-by":"crossref","unstructured":"Perreault RE, et al. Oral Tranexamic Acid Reduces Transfusions in Total Knee Arthroplasty. J Arthroplasty. 2017;32(10):2990\u20134.","DOI":"10.1016\/j.arth.2017.03.063"},{"key":"660_CR14","doi-asserted-by":"crossref","unstructured":"Yuan X, et al. Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. J Arthroplasty. 2017;32(9):2738\u201343.","DOI":"10.1016\/j.arth.2017.03.059"},{"issue":"1","key":"660_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5792\/ksrr.16.074","volume":"29","author":"QJ Lee","year":"2017","unstructured":"Lee QJ, Ching WY, Wong YC. Blood sparing efficacy of oral tranexamic acid in primary total knee arthroplasty: a randomized controlled trial. Knee Surg Relat Res. 2017;29(1):57\u201362.","journal-title":"Knee Surg Relat Res"},{"issue":"2","key":"660_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.2042-7158.1970.tb08404.x","volume":"22","author":"AH Beckett","year":"1970","unstructured":"Beckett AH, Taylor JF, Kourounakis P. The absorption, distribution and excretion of pentazocine in man after oral and intravenous administration. J Pharm Pharmacol. 1970;22(2):123\u20138.","journal-title":"J Pharm Pharmacol"},{"key":"660_CR17","doi-asserted-by":"crossref","first-page":"b4012","DOI":"10.1136\/bmj.b4012","volume":"339","author":"L Hartling","year":"2009","unstructured":"Hartling L, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009;339:b4012.","journal-title":"BMJ"},{"issue":"1","key":"660_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"6","key":"660_CR19","first-page":"727","volume":"18","author":"GA Wells","year":"2000","unstructured":"Wells GA, et al. The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2000;18(6):727\u201334.","journal-title":"Appl Eng Agric"},{"issue":"3","key":"660_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/BCO.0b013e318247f1d5","volume":"23","author":"AR Bradshaw","year":"2012","unstructured":"Bradshaw AR, et al. Oral tranexamic acid reduces blood loss in total knee replacement arthroplasty. Current Orthopaedic Practice. 2012;23(3):209\u201312.","journal-title":"Current Orthopaedic Practice"},{"issue":"6","key":"660_CR21","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1213\/01.ANE.0000136770.75805.19","volume":"99","author":"E Zohar","year":"2004","unstructured":"Zohar E, et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg. 2004;99(6):1679\u201383. table of contents","journal-title":"Anesth Analg"},{"issue":"3","key":"660_CR22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.transci.2013.09.005","volume":"49","author":"M Alipour","year":"2013","unstructured":"Alipour M, et al. Effectiveness of oral Tranexamic acid administration on blood loss after knee artroplasty: a randomized clinical trial. Transfus Apher Sci. 2013;49(3):574\u20137.","journal-title":"Transfus Apher Sci"},{"issue":"9 Suppl","key":"660_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","volume":"31","author":"YA Fillingham","year":"2016","unstructured":"Fillingham YA, et al. The James A. Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous Tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplast. 2016;31(9 Suppl):26\u201330.","journal-title":"J Arthroplast"},{"issue":"1","key":"660_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2016.06.058","volume":"32","author":"QJ Lee","year":"2017","unstructured":"Lee QJ, Chang WY, Wong YC. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplast. 2017;32(1):139\u201342.","journal-title":"J Arthroplast"},{"key":"660_CR25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijsu.2014.12.023","volume":"15","author":"C Wang","year":"2015","unstructured":"Wang C, et al. Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis. Int J Surg. 2015;15:134\u20139.","journal-title":"Int J Surg"},{"issue":"12","key":"660_CR26","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1007\/s00167-012-1942-5","volume":"20","author":"SP Roy","year":"2012","unstructured":"Roy SP, et al. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2012;20(12):2494\u2013501.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"9","key":"660_CR27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.arth.2013.06.011","volume":"28","author":"G Konig","year":"2013","unstructured":"Konig G, Hamlin BR, Waters JH. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplast. 2013;28(9):1473\u20136.","journal-title":"J Arthroplast"},{"issue":"8","key":"660_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4236\/ojo.2014.48035","volume":"04","author":"S Mcgrath","year":"2014","unstructured":"Mcgrath S, Yates P, Prosser G. Oral tranexamic acid in hip and knee arthroplasty: a prospective cohort study. Open J Orthopedics. 2014;04(8):215\u201320.","journal-title":"Open J Orthopedics"},{"issue":"11","key":"660_CR29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1302\/0301-620X.95B11.31055","volume":"95-b","author":"A Irwin","year":"2013","unstructured":"Irwin A, et al. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J. 2013;95-b(11):1556\u201361.","journal-title":"Bone Joint J"},{"issue":"5","key":"660_CR30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1302\/0301-620X.83B5.11745","volume":"83","author":"N Tanaka","year":"2001","unstructured":"Tanaka N, et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br. 2001;83(5):702\u20135.","journal-title":"J Bone Joint Surg Br"},{"issue":"3","key":"660_CR31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1213\/00000539-200103000-00041","volume":"92","author":"JM Engel","year":"2001","unstructured":"Engel JM, et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg. 2001;92(3):775\u201380.","journal-title":"Anesth Analg"},{"issue":"3","key":"660_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.arth.2014.10.008","volume":"30","author":"JT Moskal","year":"2015","unstructured":"Moskal JT, Harris RN, Capps SG. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplast. 2015;30(3):365\u20138.","journal-title":"J Arthroplast"},{"issue":"8 Suppl","key":"660_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.arth.2013.04.054","volume":"28","author":"BP Gillette","year":"2013","unstructured":"Gillette BP, et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplast. 2013;28(8 Suppl):137\u20139.","journal-title":"J Arthroplast"},{"issue":"12","key":"660_CR34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.5435\/00124635-201112000-00007","volume":"19","author":"MA Mont","year":"2011","unstructured":"Mont MA, et al. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg. 2011;19(12):768\u201376.","journal-title":"J Am Acad Orthop Surg"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-017-0660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T05:44:26Z","timestamp":1509083066000},"score":1,"resource":{"primary":{"URL":"http:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-017-0660-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["660"],"URL":"https:\/\/doi.org\/10.1186\/s13018-017-0660-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737094377.793568796","asserted-by":"object"}]},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]},"article-number":"159"}}